Furthermore, Davies demonstrated that young women (<40 years) with unilateral, stage I disease and a 1st degree relative with bilateral breast cancer, were the only group to have a quality-adjusted life year benefit from contralateral prophylactic mastectomy, which was similar to that of a BRCA1/2 carrier [63]. The gene discussed is BRCA1; the disease is breast cancer.